Cover Image
Market Research Report

US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

Published by IMARC Services Pvt. Ltd. Product code 359386
Published Content info 84 Pages
Delivery time: 1-2 business days
Price
Back to Top
US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023
Published: February 4, 2018 Content info: 84 Pages
Description

The US generic drug market has witnessed a transformation over the last three decades. From less than 20% of the total prescriptions, generic drugs now account for the majority of the total prescriptions dispensed in the United States. During 2011-2017, the US generic drug market grew at a CAGR of 13% and currently represents a multibillion dollar industry. The biggest catalyst of this industry is the significantly lower price of generics compared to branded drugs. Although generics are chemically identical to their branded counterparts, they are typically sold at substantial discounts from the branded price. This has enabled governments and third-party payers to save billions of dollars in healthcare expenditures and resulted in lower copayments for patients. Other factors such as patent expiration of blockbuster innovator drugs, ageing population and an increasing prevalence of chronic diseases have also acted as catalysts for this market.

The report entitled "US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023" provides a comprehensive insight into the historical and current trends as well as the future prospects of the generic drug market in the United States. This study serves as an exceptional tool to understand the sales trends, volume trends, growth, key segments, competitive structure, regulations, major manufacturer, major distributors, top drugs, manufacturing requirements, opportunities and future prospects of the US generic drug market. This report can serve as an excellent guide for manufacturers, consultants, researchers, marketing strategists and all those who plan to foray into the US generic drug market in any form.

Key Questions Answered in This Report:

  • Historical, current and future sales trends in the US generic drug market?
  • Historical, current and future prescription trends in the US generic drug market?
  • Performance of the US generic drug market compared to the US pharmaceutical market?
  • Performance of the US generic drug market compared to other major generic drug markets?
  • Structure of the US generic drug market?
  • Competitive landscape in the US generic drug market?
  • Top US generic drug manufacturers and their market shares?
  • Distribution of generic drugs in the US?
  • Top US generic drug distributors and their market shares?
  • Most prescribed generic drugs in the US?
  • Pricing analysis of generic drugs?
  • Value chain analysis of generic drugs in the US?
  • Regulations in the US generic drug market?
  • Manufacturing process of generic drugs?
  • Machinery and raw material requirements for manufacturing generic drugs?
  • Key success and risk factors in the US generic drug market?
Table of Contents
Product Code: SR1018B12_Report

Table of Contents

1. Preface

2. Research Methodology and Market Definitions

3. Executive Summary

4. US Generic Drug Market - Introduction

  • 4.1. What are Generic Drugs?
  • 4.2. Unbranded and Branded Generics
  • 4.3. Authorized Generics
  • 4.4. Commoditized and Specialty Generics

5. Why is the US Generic Drug Market so Lucrative

  • 5.1. Patent Expiry of Blockbuster Drugs
  • 5.2. Significant Price Differential between Generics and Innovator Drugs
  • 5.3. Savings for the Government and Third Party Payers
  • 5.4. Incentives for Dispensing and Prescribing Generic Drugs
  • 5.5. Reimbursement and Lower Copayments
  • 5.6. Biosimilars

6. Global Generic Drug Market

  • 6.1. Market Performance
    • 6.1.1. Volume Trends
    • 6.1.2. Value Trends
  • 6.2. Market Breakup by Country
  • 6.3. Market Forecast
  • 6.4. Most Prescribed Generic and Branded Drugs

7. US Generic Drug Market

  • 7.1. US Pharmaceutical Market Performance
    • 7.1.1. Volume Trends
    • 7.1.2. Value Trends
    • 7.1.3. Market Breakup by Type
    • 7.1.4. Market Forecast
  • 7.2. US Generic Drug Market Performance
    • 7.2.1. Volume Trends
    • 7.2.2. Value Trends
    • 7.2.3. Market Breakup by Segment
    • 7.2.4. Market Forecast

8. US Generic Drug Market - Market Breakup by Segment

  • 8.1. Unbranded Generics
  • 8.2. Branded Generics

9. US Generic Drug Market - SWOT Analysis

  • 9.1. Strengths
  • 9.2. Weaknesses
  • 9.3. Opportunities
  • 9.4. Threats

10. US Generic Drug Market - Value Chain Analysis

  • 10.1. Research and Development
  • 10.2. Manufacturing
  • 10.3. Marketing and Distribution

11. Pricing Mechanism and Profit Margins at Various Levels of the Supply Chain

12. Porter's Five Forces Analysis

  • 12.1. Overview
  • 12.2. Bargaining Power of Buyers
  • 12.3. Bargaining Power of Suppliers
  • 12.4. Degree of Rivalry
  • 12.5. Threat of New Entrants
  • 12.6. Threat of Substitutes

13. US Generic Drug Market- Competitive Landscape

  • 13.1. US Generic Drug Market - Competitive Structure
  • 13.2. US Generic Drug Market - Sales Breakup of Key Players
  • 13.3. US Generic Drug Market - Volume Breakup of Key Players
  • 13.4. US Generic Drug Market - Most Prescribed Generic Drugs
  • 13.5. US Generic Drug Market - Market Breakup by Distribution
  • 13.6. US Generic Drug Market - Pricing Dynamics

14. Regulations in the US Generic Drug Industry

  • 14.1. Overview of Pharmaceutical Regulations
  • 14.2. Drug Applications
  • 14.3. Patents and Market Exclusivity
  • 14.4. Regulatory Requirements for Generic Drugs
  • 14.5. The Hatch-Waxman Act
  • 14.6. Certifications
  • 14.7. Other Important Considerations

15. US Generic Drug Market: Key Success Factors

16. US Generic Drug Market: Road Blocks

17. Requirements for Setting Up a Generic Drug Manufacturing Plant

  • 17.1. Manufacturing Process
  • 17.2. Raw Material Requirements
  • 17.3. Raw Materials Pictures
  • 17.4. Land and Construction Requirements
  • 17.5. Machinery and Infrastructure Requirements
  • 17.6. Machinery Pictures
  • 17.7. Plant Layout
  • 17.8. Packaging Requirements
  • 17.9. Utility Requirements
  • 17.10. Manpower Requirements

18. US Generic Drug Market - Key Company Profiles

  • 18.1. Teva
  • 18.2. Mylan
  • 18.3. Actavis
  • 18.4. Sandoz
  • 18.5. Sun Pharma
  • 18.6. Par Pharmaceuticals
  • 18.7. Endo Pharmaceuticals
  • 18.8. Lupin Pharmaceuticals
  • 18.9. Dr Reddy's
  • 18.10. Hospira

List of Figures

  • Figure 4-1: Structure of the Pharmaceutical Industry
  • Figure 4-2: Classification of Generic Drugs
  • Figure 5-1: US: Patent Expiry Exposure (in Billion US$), 2010-2019
  • Figure 5-2: US: Savings from Generic Drugs (in Billion US$), 2006-2017
  • Figure 6-1: Global: Generic Drug Market: Sales Value (in Billion US$), 2011-2017
  • Figure 6-2: Global: Generic Drug Market: Sales Volume (in Billion Standards Units), 2011-2017
  • Figure 6-3: Global: Generic Drug Market: Sales Value Breakup by Country (in %), 2017
  • Figure 6-4: Global: Generic Drug Market: Sales Volume Breakup by Country (in %), 2017
  • Figure 6-5: Global: Generic Drug Market Forecast: Sales Value (in Billion US$), 2018-2023
  • Figure 6-6: Global: Generic Drug Market: Sales Volume (in Billion Standards Units), 2018-2023
  • Figure 7-1: US: Pharmaceutical Market: Sales Volume (in Million Prescriptions), 2011-2017
  • Figure 7-2: US: Pharmaceutical Market: Sales Value (in Billion US$), 2011-2017
  • Figure 7-3: US: Pharmaceutical Market Forecast: Sales Value (in Billion US$), 2018-2023
  • Figure 7-4: US: Pharmaceutical Market: Sales Volume (in Million Prescriptions), 2018-2023
  • Figure 7-5: US: Pharmaceutical Market: Sales Volume Breakup of Branded and Generic Drugs (in %), 2011 and 2017
  • Figure 7-6: US: Pharmaceutical Market: Sales Value Breakup of Branded and Generic Drugs (in %), 2011 and 2017
  • Figure 7-7: US: Generic Drug Market: Sales Volume (in Million Prescriptions), 2011-2017
  • Figure 7-8: US: Generic Drug Market Forecast: Sales Volume (in Million Prescriptions), 2018-2023
  • Figure 7-9: US: Generic Drug Market: Sales Value (in Billion US$), 2011-2017
  • Figure 7-10: US: Generic Drug Market Forecast: Sales Value (in Billion US$), 2018-2023
  • Figure 7-11: US: Generic Drug Market: Market Breakup by Segment (in %), 2011-2017
  • Figure 8-1: US: Generic Drug Market: SWOT Analysis
  • Figure 9-1: US: Generic Drug Market: Value Chain Analysis
  • Figure 10-1: US: Generic Drug Market: Pricing Mechanism and Profit Margins at the Various Levels of the Supply Chain
  • Figure 11-1: US: Generic Drug Market: Porter's Five Forces Analysis
  • Figure 12-1: US: Generic Drug Market: Sales Share of Top Players (in %), 2017
  • Figure 12-2: US: Generic Drug Market: Volume Share of Top Players (in %), 2017
  • Figure 12-3: US: Generic Drug Market: Volume Share by Distribution (in %), 2017
  • Figure 12-4: US: Generic Drug Prices as a Percentage of Branded Drug Prices - Based on Number of Competitors
  • Figure 16-1: US: Generic Drug Market: Detailed Process Flow
  • Figure 16-2: US: Generic Drug Market: Raw Material Requirements
  • Figure 16-3: US: Generic Drug Market: Plant Layout
  • Figure 16-4: US: Generic Drug Market: Packaging Requirements

List of Tables

  • Table 4-1: US: Sales and Patent Expiry of Major Drugs Expected to Lose Patent Protection (in Billion US$)
  • Table 4-2: US: Expenses of Generic and Branded Drug Manufacturers (in %)
  • Table 5-1: Sales Volume and Growth in Major Markets, 2017
  • Table 5-2: Volume Performance of Top Generic Drugs (in Million Prescriptions), 2017
  • Table 5-3: Global: Branded Drug Market: Volume Performance of Top Branded Drugs (in Million Prescriptions), 2017
  • Table 7-1: US: generic Drug Market: Sales Performance of Top Players (in Billion US$), 2017
  • Table 7-2: US: Generic Drug Market: Volume Performance of Top Players (in Billion Units), 2017
  • Table 7-3: US: Generics Market: Volume Performance of Top Generic Drugs (in Million Prescriptions), 2017
  • Table 9-1: US: Overview of Pharmaceutical Regulations
  • Table 16-1: US: Generic Drug Market: Land and Construction Requirements
  • Table 16-2: US: Generic Drug Market: Machinery and Infrastructure Requirements
  • Table 16-3: US: Generic Drug Market: Utility Requirements
  • Table 16-4: US: Generic Drug Market: Manpower Requirements
Back to Top